Clinical Trial: Effect of Combined Hormonal Contraceptiveson Free Androgen Index (FAI) in Polycystic Ovary Syndrome:Drospirenone-Ethinyl Estradiol (DRSP-EE) Versus Cyproterone Acetate-Ethinyl Estradiol (CPA-EE)

U.S., Nov. 4 -- ClinicalTrials.gov registry received information related to the study (NCT07911709) titled 'Effect of Combined Hormonal Contraceptiveson Free Androgen Index (FAI) in Polycystic Ovary Syndrome:Drospirenone-Ethinyl Estradiol (DRSP-EE) Versus Cyproterone Acetate-Ethinyl Estradiol (CPA-EE)' on Oct. 28.

Brief Summary: The goal of this clinical trial is to learn if drug Drospirenone ethinyl estradiol works better than drug Cyproterone acetate ethinyl estradiol to treat PCOS. The main questions it aims to answer are

What medical problems do participants have when taking drug Drospirenone ethinyl estradiol and Cyproterone acetate ethinyl estradiol? Researchers will compare drug Drospirenone ethinyl estradiol to drug Cyproterone ac...